- A Multi-omics Study of Adenomyosis
- A Prospective Study of Diagnostic Accuracy of Ultrasound
- Adenomyosis and Ulipristal Acetate
- Adenomyosis: Genomic Mechanisms and Biological Response
- Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
- Clinical and Molecular Study of Endometriosis and Adenomyosis
- Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis
- Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)
- Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis
- Determination of the Incidence of Endometriosis and or Adenomyosis in Patients Diagnosed With Polycystic Ovary Syndrome, or the Incidence of Polycystic Ovary Syndrome in Patients Diagnosed With Endometriosis and or Adenomyosis
- Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis
- Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
- Dienogest for Treatment of Adenomyotic Uteri
- Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?
- Effect of Addition of Steroids on Duration of Analgesia
- Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis
- Efficacy of Acupuncture on Chronic Pelvic Pain in Women With Endometriosis or Adenomyosis
- Electronic Catheter Stethoscope
- Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis
- Factors Associated With Adenomyosis and a Clinical Scoring System for the Diagnosis
- Health-Related QoL Among Women Receiving Hysterectomy in NTUH
- High-intensity Focused Ultrasound in Treatment of Uterine Adenomyosis
- Histopathological Diagnosis of Adenomyosis
- Levonorgestrel Intrauterine System and Adenomyosis
- Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis
- Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri
- LNG-IUS for Treatment of Dysmenorrhea
- Long-term Use of Mifepristone in the Treatment of Adenomyosis
- Low Molecular Weight Heparin on the Adenomyosis Patients’IVF-ET Outcome
- Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer.
- New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma
- Norwegian Adenomyosis Study I
- Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis
- Norwegian Adenomyosis Study III: Peristalsis
- Observational Study of Patients Suffering From Endometriosis and Adenomyosis
- Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy
- Oxytocin in MRI-HIFU
- Paracervical Block in Laparoscopic Hysterectomy
- Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
- Quality of Life After Hysterectomy (AdenoQOL)
- Radiofrequency Ablation of Adenomyosis
- Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis
- Single-port Access Laparoscopic-assisted Vaginal Hysterectomy
- Surgical Success After Laparoscopic vs Abdominal Hysterectomy
- The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
- The Effect of Adenomoyosis on Pregnancy Outcomes
- The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis
- To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy
- Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU)
- Use of Dexamethasone in Uterine Artery Embolization
- Uterine Artery Embolization for Symptomatic Fibroids
- Vaginal Bromocriptine for Treatment of Adenomyosis
- Validation of the Adenomyosis Calculator
- What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography
Clinical Trials
- A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
- Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma
- Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
- Cabozantinib in Advanced Adrenocortical Carcinoma
- Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
- Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
- Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
- Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
- Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
- Evaluation of Side Effects of Mitotane
- German Adrenocortical Carcinoma Registry
- Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
- IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery
- International Pediatric Adrenocortical Tumor Registry
- Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma
- Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)
- Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
- Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
- Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
- Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
- Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
- Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma
- Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma
- Possible New Therapy for Advanced Cancer
- S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
- Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
- Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients
- Structured Evaluation of adRENal Tumors Discovered Incidentally – Prospectively Investigating the Testing Yield
- Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
- Sunitinib in Refractory Adrenocortical Carcinoma
- Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
- Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
- The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma
- Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
- Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
- Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
- Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cure
- Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP2 Passive Case Detection
- Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring
- Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
- Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole
- Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
- Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum Malaria
- Prospective Study on Efficacy and Safety of Acoziborole (SCYX-7158) in Patients Infected by Human African Trypanosomiasis Due to T.b. Gambiense
- Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects
- Trial of DB289 for the Treatment of Stage I African Trypanosomiasis
- A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection
- A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex
- A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases
- A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)
- A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
- An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
- Comparison of 2′,3′-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
- Effect of Cenicriviroc on HIV Neurocognitive Impairment
- Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals
- Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder
- Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
- Maraviroc and NeuroAIDS Pathogenesis
- Men Who Have Sex With Men (MSM) Neurocog 1&2 Study
- PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
- Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1
- Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy
- A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata
- A Phase 2 Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
- A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
- A Phase 3 Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA2)
- A Phase II Study in Patients With Alopecia Areata
- A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
- A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
- A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
- A Study of JNJ-64304500 in Participants With Alopecia Areata
- A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in the Treatment of Subjects With Moderate-to-Severe Alopecia Areata
- A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects
- A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata
- A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata
- Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata
- Aldara for the Treatment of Extensive Alopecia Areata
- Alefacept in Patients With Severe Scalp Alopecia Areata
- Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata
- Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%
- Childhood Alopecia Areata Study Using the 308-nm Excimer Laser
- Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
- Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP
- Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss – Alopecia Areata
- Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids
- Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata
- Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation
- Efficacy and Safety of LH-8 in Paediatric Alopecia Areata
- Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata
- Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata
- Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata
- Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata
- Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata
- Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.
- Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females
- Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
- European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
- Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
- Excimer Light for Alopecia Areata
- Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
- Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
- Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling
- Intralesional Steroids in the Treatment of Alopecia Areata
- Intralesional Vitamin D in Alopecia Areata
- Jaktinib Dihydrochloride Monohydrate in Severe Alopecia Areata
- LEO 124249 Ointment in the Treatment of Alopecia Areata
- Modified SALT Score for Alopecia Areata
- Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
- Response of Topical Capsaicin in Alopecia Areata
- Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
- Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata
- Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
- Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids
- Stem Cell Educator Therapy in Alopecia Areata
- Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
- Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
- Superficial Cryotherapy Versus Microneedling in Alopecia Areata
- The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
- The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia Areata
- The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata
- The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
- Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata
- Topical Crisaborole in Patients With Alopecia Areata
- Topical Garlic Concentrate for Alopecia Areata in Children
- Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata
- Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
- TREg Activation in the Treatment of the PELADE (Alopecia Areata)
- Vytorin in the Treatment of Alopecia Areata
- Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis
- Alopecia Areata Registry
- ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
- Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata
- Efalizumab in the Treatment of Alopecia, Phase II
- Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
- Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
- Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
- Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants
- Tofacitnib for the Treatment of Alopecia Areata and Variants
- Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
- 4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?
- A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.
- A Phase I of OsrhAAT in Healthy Volunteers
- A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiMZ Subjects
- A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)
- A Study of Belcesiran in Patients With A1ATD-Associated Liver Disease
- A Study of DCR-A1AT in Healthy Adult Volunteers and Patients With A1ATD-Associated Liver Disease
- A Study to Assess Safety and PK of Liquid Alpha₁-Proteinase Inhibitor (Human) in Treating Alpha₁-Antitrypsin Deficiency
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency
- AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry
- Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
- Alpha-1 Carrier Genomics Study
- Alpha-1 Coded Testing(ACT) Study
- Alpha-1 Foundation DNA and Tissue Bank
- Alpha-1 Foundation Research Registry
- Alpha-1 Research Registry
- Alpha1-antitrypsin Deficiency Registry
- Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency
- An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATLD)
- Aralast alpha1-proteinase Inhibitor Surveillance Study
- ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) Study
- Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals
- Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults
- COPD Exacerbation Blood and Urine Biomarkers Study
- EARCO REGISTRY. History Of Patients With Alpha-1 Antitrypsin
- Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)
- Effects of Different Exercise Training Modalities in Alpha-1 Antitrypsin Deficiency Patients
- Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients
- Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 – Proteinase Inhibitor)
- Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency
- Environment Effect on Six-Minute Walk Test Performance
- Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency
- Evaluate Efficacy and Safety of “Kamada-AAT for Inhalation” in Patients With AATD
- Evaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ Genotype
- Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype
- Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency
- Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency
- Functional and Structural Lung Imaging in Chronic Obstructive Pulmonary Disease
- GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study
- Long-Term Follow-up Study of ADVM-043
- Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE)
- Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency
- Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema
- Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency
- Pharmacokinetic Study of ARALAST (Human Alpha1- PI)
- Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency
- Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation”
- Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency
- Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)
- Respreeza® Self-administration and Learning Program (AmAREtTI Study)
- Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency
- Safety and Pharmacokinetics of Alpha-1 MP in Patients With Alpha1-Antitrypsin Deficiency
- Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
- Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency
- Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home
- Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency
- Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels
- Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency
- Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency
- Study of ARO-AAT in Normal Adult Volunteers
- Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
- Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
- Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
- The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency
- The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency
- The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency
- A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis
- Biomarker for Mannosidosis Disease (BioMannosidosis)
- Clinical Biomarkers in Alpha-mannosidosis
- Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
- Evaluation of Long-term Efficacy of Treatment With Lamazym
- Expanded Access to Velmanase Alfa
- Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis
- Lamazym Aftercare Study
- Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients
- Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis
- Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
- Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis
- A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
- Evaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity Pneumonitis
- Immune Response in Hypersensitivity Pneumonitis
- Pulmonary Rehabilitation in Patients With Chronic Fibrotic Hypersensitivity Pneumonitis
- Research for Specific Proteins of Interest for the Serological Diagnosis of Bird Fancier’s Lung
- Wind Instruments’ Fungal Contamination
- Multi-Center Development of a Novel Diagnostic Test for Alzheimer’s Disease
- Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer’s Disease
- The Chinese Familial Alzheimer’s Network